Results 21 to 30 of about 228,341 (358)

Telomeres in Interstitial Lung Disease [PDF]

open access: yesJournal of Clinical Medicine, 2021
Interstitial lung diseases (ILD) encompass a group of conditions involving fibrosis and/or inflammation of the pulmonary parenchyma. Telomeres are repetitive DNA sequences at chromosome ends which protect against genome instability. At each cell division, telomeres shorten, but the telomerase complex partially counteracts progressive loss of telomeres ...
Stock, C, Renzoni, E
openaire   +4 more sources

Cluster features in fibrosing interstitial lung disease and associations with prognosis

open access: yesBMC Pulmonary Medicine, 2023
Background Clustering is helpful in identifying subtypes in complex fibrosing interstitial lung disease (F-ILD) and associating them with prognosis at an early stage of the disease to improve treatment management.
Yuanying Wang   +5 more
doaj   +1 more source

Elevated Serum Amyloid a Levels Are not Specific for Sarcoidosis but Associate with a Fibrotic Pulmonary Phenotype

open access: yesCells, 2021
Elevated Serum Amyloid A (SAA) levels have been found in several inflammatory diseases, including sarcoidosis. SAA is suggested to be involved in sarcoidosis pathogenesis by involvement in granuloma formation and maintenance.
Els Beijer   +5 more
doaj   +1 more source

Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE

open access: yesBMC Pulmonary Medicine, 2023
Background Pulmonary fibrosis (PF) is caused by a heterogeneous group of diseases, with a high inter-individual variability in disease trajectory. Identifying disease progression in patients with PF has impact on clinical management decisions.
Gizal Nakshbandi   +9 more
doaj   +1 more source

Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review

open access: yesEuropean Respiratory Review, 2021
Over the past three decades, an increasing number of publications have reported the association between interstitial lung disease (ILD) and anti-neutrophil cytoplasmic antibody (ANCA) or ANCA-associated vasculitis (AAV). With this increased awareness, we
Suha Kadura, Ganesh Raghu
doaj   +1 more source

Airway involvement in interstitial lung disease [PDF]

open access: yes, 2006
PURPOSE OF REVIEW: After briefly discussing several ways to approach airway involvement in interstitial lung diseases - by diagnostic methodologies used to assess it, considering different topographical involvement, related to its presence in the diffuse
Robalo-Cordeiro, C
core   +1 more source

Interstitial lung disease: course report [PDF]

open access: yesBreathe, 2020
The @EuroRespSoc course on ILD https://bit.ly/32PtzfH.
Michael Kreuter, Vitalii Poberezhets
openaire   +2 more sources

Interstitial lung disease [PDF]

open access: yesEuropean Respiratory Review, 2013
This article reviews the most important articles published in interstitial lung disease, as reviewed during the Clinical Year in Review session at the 2012 annual European Respiratory Society Congress in Vienna, Austria.Since the recent international guidelines for the management of idiopathic pulmonary fibrosis (IPF), important new evidence is ...
openaire   +4 more sources

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis

open access: yesRespiratory Research, 2022
Background Hypersensitivity pneumonitis (HP) is a type of interstitial lung disease (ILD) with a variable disease course and prognosis ranging from inflammatory and self-limiting to irreversible and progressive pulmonary fibrosis.
Thomas Skovhus Prior   +4 more
doaj   +1 more source

Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study

open access: yesFrontiers in Pharmacology, 2022
Background: Limited data are available regarding the entire spectrum of interstitial lung disease with a progressive fibrosing feature. We investigated the prevalence and prognostic predictive characteristics in patients with PF-ILD.Methods: This ...
Yuanying Wang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy